← All organizations

MediWound Ltd

For profitContributed to NMEWebsite ↗

Also known as: MediWound Ltd | MediWound, Ltd. | MEDIWOUND, LTD

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

First marketed drug

First NDA

Last known activity

Apr 30, 2025

Timeline

2000s

Jun 1, 2001
MediWound Ltd— Founded

2020s

Dec 28, 2022
anacaulase— Marketing Organization
Dec 28, 2022
anacaulase— NDA Organization
Dec 28, 2022
anacaulase— NDA Secondary Org

Drugs by trial phase (2 distinct, 9 trials)

Phase 3 (2 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

anacaulase

Recent trials (13)

NCT04040660Lead sponsorN/A—
NCT06690177Lead sponsorPhase 2Apr 30, 2025
NCT06568627Lead sponsorPhase 3Nov 30, 2024
NCT05157763Lead sponsorPhase 1/Phase 2Jun 30, 2021
NCT05157763Study directorPhase 1/Phase 2Jun 30, 2021
NCT04817228Study chairPhase 2Apr 21, 2021
NCT04817228Lead sponsorPhase 2Apr 21, 2021
NCT03588130Lead sponsorPhase 2Aug 31, 2018
NCT02148705Lead sponsorPhase 3Apr 1, 2015
NCT02278718Lead sponsorPhase 3Nov 1, 2014
NCT02278718Study chairPhase 3Nov 1, 2014
NCT02278718Study directorPhase 3Nov 1, 2014
NCT02020746Lead sponsorPhase 2Aug 1, 2014

Details

Founded: Yavne, IL Jun 1, 2001
First NDA: Dec 28, 2022
Last known activity: Apr 30, 2025

Designations held

Orphan drug